All Stories

  1. The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study

    Article • Frontiers in Medicine, May 2026, Frontiers

    Dr Matteo Piga

  2. VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries

    Article • Seminars in Arthritis and Rheumatism, April 2026, Elsevier

    Dr Matteo Piga

  3. Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials

    Article • Journal of Clinical Medicine, March 2026, MDPI AG

    Dr Matteo Piga

  4. Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network

    Article • Frontiers in Immunology, March 2026, Frontiers

    Dr Matteo Piga

  5. Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study

    Article • The Lancet Rheumatology, March 2026, Elsevier

    Dr Matteo Piga

  6. Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology

    Article • Annals of the Rheumatic Diseases, March 2026, Elsevier

    Dr Matteo Piga

  7. The use of non-TNF targeted biologics in Behçet’s disease: real-life data from the International AIDA Network Behçet’s Disease Registry

    Article • Rheumatology, February 2026, Oxford University Press (OUP)

    Dr Matteo Piga

  8. Machine Learning for MRI Classification of Systemic Lupus Erythematous Patients with and without Neuropsychiatric Events

    Article • Journal of Imaging Informatics in Medicine, February 2026, Springer Science + Business Media

    Dr Matteo Piga

  9. Rationale for investigating the use of anifrolumab in neuropsychiatric systemic lupus erythematosus: a combined narrative and case-based systematic literature review

    Article • Frontiers in Immunology, February 2026, Frontiers

    Dr Matteo Piga

  10. Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry

    Article • American Journal of Ophthalmology, February 2026, Elsevier

    Dr Matteo Piga

  11. Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries

    Article • Frontiers in Medicine, January 2026, Frontiers

    Dr Matteo Piga

  12. Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort

    Article • Lupus Science & Medicine, January 2026, BMJ

    Dr Matteo Piga

  13. The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways

    Article • Scientific Reports, December 2025, Springer Science + Business Media

    Dr Matteo Piga

  14. International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by lupus patients: the SLE Knowledge Assessment Score (SLAKE)

    Article • Rheumatology, December 2025, Oxford University Press (OUP)

    Dr Matteo Piga

  15. The impact of demographics on organ damage in Behçet’s syndrome: a cross-sectional analysis of the international PROBE cohort

    Article • Rheumatology, November 2025, Oxford University Press (OUP)

    Dr Matteo Piga

  16. Risk of major organ involvement in Behçet’s patients with mucocutaneous onset: data from the AIDA Network Registry

    Article • Rheumatology, November 2025, Oxford University Press (OUP)

    Emre Bilgin, Dr Matteo Piga

  17. The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry

    Article • Ophthalmology and Therapy, November 2025, Springer Science + Business Media

    Emre Bilgin, Dr Matteo Piga

  18. Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study

    Article • European Journal of Internal Medicine, November 2025, Elsevier

    Dr Matteo Piga

  19. Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)

    Article • Biologics Targets and Therapy, October 2025, Taylor & Francis

    Dr Matteo Piga

  20. Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study

    Article • Seminars in Arthritis and Rheumatism, October 2025, Elsevier

    Dr Matteo Piga

  21. Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry

    Article • Frontiers in Medicine, July 2025, Frontiers

    Dr Matteo Piga

  22. The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

    Article • Reumatismo, July 2025, PAGEPress Publications

    Dr Matteo Piga

  23. ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

    Article • The Lancet Rheumatology, July 2025, Elsevier

    Dr. Dafna D Gladman, Dr Matteo Piga

  24. Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus

    Article • Journal of Autoimmunity, July 2025, Elsevier

    Dr Matteo Piga

  25. Lupus serology: off target but still relevant to the treat-to-target strategy in systemic lupus erythematosus

    Article • Rheumatology, June 2025, Oxford University Press (OUP)

    Dr Matteo Piga

  26. Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force

    Article • Autoimmunity Reviews, April 2025, Elsevier

    Dr Matteo Piga

  27. Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network

    Article • Frontiers in Pharmacology, March 2025, Frontiers

    Dr Matteo Piga

  28. Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial

    Article • Annals of the Rheumatic Diseases, March 2025, Elsevier

    Dr Matteo Piga

  29. Disease activity and disability influence CV risk estimation and management of rheumatoid arthritis patients

    Article • European Journal of Internal Medicine, March 2025, Elsevier

    Dr Matteo Piga

  30. Immunomodulation for accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus

    Article • Autoimmunity Reviews, March 2025, Elsevier

    Dr Matteo Piga

  31. Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry

    Article • Joint Bone Spine, March 2025, Elsevier

    Dr Matteo Piga

  32. Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry

    Article • Frontiers in Pharmacology, February 2025, Frontiers

    Dr Matteo Piga

  33. VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management

    Article • Annals of Hematology, January 2025, Springer Science + Business Media

    Dr Matteo Piga

  34. The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2025, Springer Science + Business Media

    Dr Matteo Piga

  35. Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study

    Article • Lupus Science & Medicine, January 2025, BMJ

    Dr Matteo Piga

  36. Levels of physical activity in a large international cohort of patients with systemic lupus erythematosus

    Article • Lupus Science & Medicine, January 2025, BMJ

    Dr Matteo Piga

  37. Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology

    Article • European Journal of Internal Medicine, January 2025, Elsevier

    Dr Matteo Piga

  38. Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project

    Article • Arthritis & Rheumatology, December 2024, Wiley

    Dr Matteo Piga

  39. Sex Differences in Cardiovascular Risk Profiles of Patients with Rheumatoid Arthritis: Results from an Italian Multicentre Cohort

    Article • Journal of Clinical Medicine, November 2024, MDPI AG

    Dr Matteo Piga

  40. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study

    Article • Arthritis & Rheumatology, October 2024, Wiley

    Dr Matteo Piga

  41. Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS)

    Article • Clinical Practice and Epidemiology in Mental Health, August 2024, Bentham Science Publishers

    Dr Giuseppe Carrà, Dr Matteo Piga

  42. Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study

    Article • The Journal of Rheumatology, July 2024, The Journal of Rheumatology

    Dr Matteo Piga

  43. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

    Article • Annals of the Rheumatic Diseases, July 2024, Elsevier

    Dr Matteo Piga

  44. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

    Article • Seminars in Arthritis and Rheumatism, June 2024, Elsevier

    Dr Matteo Piga

  45. Exploring relief for Behçet’s disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilast

    Article • Rheumatology, May 2024, Oxford University Press (OUP)

    Dr Matteo Piga

  46. Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development

    Article • Rheumatology, May 2024, Oxford University Press (OUP)

    Dr Matteo Piga

  47. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

    Article • Ocular Immunology and Inflammation, May 2024, Taylor & Francis

    Dr Matteo Piga

  48. Structural Brain MR Imaging Alterations in Patients with Systemic Lupus Erythematosus with and without Neuropsychiatric Events

    Article • American Journal of Neuroradiology, April 2024, American Society of Neuroradiology (ASNR)

    Dr Matteo Piga

  49. Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network

    Article • Ophthalmology and Therapy, March 2024, Springer Science + Business Media

    Dr Matteo Piga

  50. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Article • Clinical and Experimental Rheumatology, March 2024, Clinical and Experimental Rheumatology

    Dr Matteo Piga

  51. Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment

    Article • Clinical and Experimental Rheumatology, March 2024, Clinical and Experimental Rheumatology

    Dr Matteo Piga

  52. Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study

    Article • Rheumatology, February 2024, Oxford University Press (OUP)

    Dr Matteo Piga

  53. Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review

    Article • The Journal of Rheumatology, February 2024, The Journal of Rheumatology

    Dr Matteo Piga

  54. Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort

    Article • Autoimmunity Reviews, February 2024, Elsevier

    Dr Matteo Piga

  55. Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes

    Article • Healthcare, January 2024, MDPI AG

    Dr Matteo Piga

  56. Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study

    Article • Rheumatology, December 2023, Oxford University Press (OUP)

    Dr Matteo Piga

  57. Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study

    Article • RMD Open, December 2023, BMJ

    Dr Matteo Piga

  58. Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease

    Article • Best Practice & Research Clinical Rheumatology, December 2023, Elsevier

    Dr Matteo Piga

  59. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission

    Article • Autoimmunity Reviews, December 2023, Elsevier

    Dr Matteo Piga

  60. Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study

    Article • Lupus Science & Medicine, November 2023, BMJ

    Dr Matteo Piga

  61. Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry

    Article • Internal and Emergency Medicine, October 2023, Springer Science + Business Media

    Dr Matteo Piga

  62. The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort

    Article • Journal of Clinical Medicine, September 2023, MDPI AG

    Dr Matteo Piga

  63. Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al. The impact of cardiovascular co...

    Article • Annals of the Rheumatic Diseases, July 2023, Elsevier

    Dr Matteo Piga

  64. A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project

    Article • Frontiers in Medicine, June 2023, Frontiers

    Dr Matteo Piga

  65. Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus

    Article • Frontiers in Immunology, June 2023, Frontiers

    Dr Matteo Piga

  66. C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients

    Article • European Journal of Internal Medicine, May 2023, Elsevier

    Dr Matteo Piga

  67. Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)

    Article • Journal of Personalized Medicine, April 2023, MDPI AG

    Dr Matteo Piga

  68. Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Dr Matteo Piga

  69. Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry

    Article • Internal and Emergency Medicine, March 2023, Springer Science + Business Media

    Dr Matteo Piga

  70. Efficacité de l’anakinra dans la polysérite réfractaire : étude multicentrique italienne

    Article • Revue du Rhumatisme, December 2022, Elsevier

    Dr Matteo Piga

  71. Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study

    Article • RMD Open, December 2022, BMJ

    Dr Matteo Piga

  72. Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study

    Article • Arthritis Research & Therapy, November 2022, Springer Science + Business Media

    Dr Matteo Piga

  73. Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium

    Article • Journal of Clinical Medicine, October 2022, MDPI AG

    Dr Matteo Piga

  74. C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis

    Article • European Journal of Internal Medicine, October 2022, Elsevier

    Dr Matteo Piga

  75. The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

    Article • Frontiers in Medicine, September 2022, Frontiers

    Dr Matteo Piga

  76. Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study

    Article • Rheumatology, September 2022, Oxford University Press (OUP)

    Dr Matteo Piga

  77. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus

    Article • RMD Open, September 2022, BMJ

    Dr Matteo Piga

  78. Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology

    Article • Clinical and Experimental Rheumatology, August 2022, Clinical and Experimental Rheumatology

    Dr Matteo Piga

  79. Development and implementation of the AIDA International Registry for patients with Behçet’s disease

    Article • Internal and Emergency Medicine, July 2022, Springer Science + Business Media

    Dr Matteo Piga

  80. Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome

    Article • Frontiers in Medicine, July 2022, Frontiers

    Dr Matteo Piga

  81. Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study

    Article • Clinical and Experimental Rheumatology, July 2022, Clinical and Experimental Rheumatology

    Dr Matteo Piga

  82. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study

    Article • The Lancet Rheumatology, June 2022, Elsevier

    Dr. Zahi Touma, Prof. Luís Sousa Ines, Dr Matteo Piga

  83. Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?

    Article • Annals of the Rheumatic Diseases, May 2022, Elsevier

    Dr Matteo Piga

  84. Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity

    Article • Rheumatology, April 2022, Oxford University Press (OUP)

    Dr Matteo Piga

  85. Anakinra effectiveness in refractory polyserositis: An Italian multicenter study

    Article • Joint Bone Spine, March 2022, Elsevier

    Dr Matteo Piga

  86. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

    Article • Clinical and Experimental Rheumatology, February 2022, Clinical and Experimental Rheumatology

    Dr Matteo Piga

  87. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group

    Article • European Journal of Internal Medicine, February 2022, Elsevier

    Dr Matteo Piga

  88. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations

    Article • Clinical Reviews in Allergy & Immunology, January 2022, Springer Science + Business Media

    Dr Matteo Piga

  89. Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome

    Article • Frontiers in Medicine, December 2021, Frontiers

    Dr Matteo Piga

  90. Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus

    Article • Clinical and Experimental Rheumatology, October 2021, Clinical and Experimental Rheumatology

    Dr Matteo Piga

  91. Whole-Body MRI in Rheumatology: Major Advances and Future Perspectives

    Article • Diagnostics, September 2021, MDPI AG

    Dr Matteo Piga

  92. Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study

    Article • The Lancet Rheumatology, September 2021, Elsevier

    Dr Matteo Piga

  93. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis

    Article • Clinical Rheumatology, August 2021, Springer Science + Business Media

    Dr Matteo Piga

  94. Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic

    Article • Rheumatology, August 2021, Oxford University Press (OUP)

    Dr Matteo Piga

  95. Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis

    Article • Frontiers in Cardiovascular Medicine, July 2021, Frontiers

    Dr Matteo Piga

  96. Targeted Therapies in Axial Psoriatic Arthritis

    Article • Frontiers in Genetics, June 2021, Frontiers

    Dr Matteo Piga

  97. Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?

    Article • Current Pharmaceutical Design, June 2021, Bentham Science Publishers

    Dr Panagiotis Paliogiannis, Dr Salvatore Sotgia, Dr Matteo Piga, Arduino Mangoni

  98. Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs

    Article • Medicine, April 2021, Wolters Kluwer Health

    Dr Matteo Piga

  99. Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome)

    Article • European Respiratory Journal, April 2021, European Respiratory Society (ERS)

    Professor Alfredo Vannacci, Dr Matteo Piga

  100. Rheumatoid arthritis: Extra-articular manifestations and comorbidities

    Article • Autoimmunity Reviews, April 2021, Elsevier

    Dr Matteo Piga

  101. Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review

    Article • Rheumatology, March 2021, Oxford University Press (OUP)

    Dr Matteo Piga

  102. Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?

    Article • Annals of the Rheumatic Diseases, March 2021, Elsevier

    Dr Matteo Piga

  103. Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis

    Article • Open Access Rheumatology Research and Reviews, March 2021, Taylor & Francis

    Dr Matteo Piga

  104. Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review

    Article • BioDrugs, February 2021, Springer Science + Business Media

    Dr Matteo Piga

  105. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

    Article • Journal of Clinical Medicine, January 2021, MDPI AG

    Dr Matteo Piga

  106. Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud’s arthropathy and a distinctive MRI pattern

    Article • Rheumatology, January 2021, Oxford University Press (OUP)

    Dr Matteo Piga

  107. Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2021, SAGE Publications

    Dr Matteo Piga

  108. Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort

    Article • Arthritis Research & Therapy, November 2020, Springer Science + Business Media

    Dr Matteo Piga

  109. Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study

    Article • Microvascular Research, September 2020, Elsevier

    Dr Matteo Piga

  110. Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties

    Article • Rheumatology, August 2020, Oxford University Press (OUP)

    Dr Matteo Piga

  111. Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network

    Article • Mediators of Inflammation, August 2020, Wiley

    Dr Matteo Piga

  112. Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI)

    Article • RMD Open, July 2020, BMJ

    Dr Matteo Piga

  113. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting

    Article • Arthritis & Rheumatology, June 2020, Wiley

    Dr Matteo Piga

  114. Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes

    Article • Frontiers in Medicine, February 2020, Frontiers

    Dr Matteo Piga

  115. Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

    Article • Arthritis Research & Therapy, January 2020, Springer Science + Business Media

    Dr Matteo Piga

  116. Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age

    Article • Current Pharmaceutical Design, December 2019, Bentham Science Publishers

    Dr Matteo Piga, Dr Salvatore Sotgia, Stefania Bassu

  117. Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort

    Article • Rheumatology, December 2019, Oxford University Press (OUP)

    Dr Matteo Piga

  118. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Dr Matteo Piga

  119. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography

    Article • European Journal of Internal Medicine, November 2019, Elsevier

    Dr Matteo Piga

  120. Treatment target in newly diagnosed Systemic Lupus Erythematosus

    Article • Arthritis Care & Research, October 2019, Wiley

    Dr Matteo Piga

  121. Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet’s Syndrome

    Article • Open Access Rheumatology Research and Reviews, October 2019, Taylor & Francis

    Dr Alberto Floris, Dr Matteo Piga

  122. The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia

    Article • Rheumatology, June 2019, Oxford University Press (OUP)

    Dr Matteo Piga, Professor Rosa Sorrentino

  123. SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS

    Article • Annals of the Rheumatic Diseases, June 2019, Elsevier

    Dr Matteo Piga

  124. Effect of carotid image-based phenotypes on cardiovascular risk calculator: AECRS1.0

    Article • Medical & Biological Engineering & Computing, April 2019, Springer Science + Business Media

    Dr Matteo Piga

  125. Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response

    Article • Frontiers in Pharmacology, April 2019, Frontiers

    Dr Matteo Piga

  126. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)

    Article • Frontiers in Cardiovascular Medicine, February 2019, Frontiers

    Dr Matteo Piga

  127. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning–Based Tissue Characterization

    Article • Current Atherosclerosis Reports, January 2019, Springer Science + Business Media

    Dr Matteo Piga

  128. Nonlinear model for the carotid artery disease 10‐year risk prediction by fusing conventional cardiovascular factors to carotid ultrasound image phenotypes: A Japanese diabetes cohort study

    Article • Echocardiography, January 2019, Wiley

    Dr Matteo Piga

  129. How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria

    Article • Arthritis & Rheumatology, November 2018, Wiley

    Dr Matteo Piga, Dr. Zahi Touma

  130. Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

    Article • Drugs in Context, November 2018, BioExcel

    Dr Matteo Piga

  131. Ultrasonography in psoriatic arthritis: which sites should we scan?

    Article • Annals of the Rheumatic Diseases, October 2018, Elsevier

    Dr Matteo Piga

  132. AIF-1 gene does not confer susceptibility to Behçet’s disease: Analysis of extended haplotypes in Sardinian population

    Article • PLOS One, September 2018, PLOS

    Dr Matteo Piga, Professor Rosa Sorrentino

  133. The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the ...

    Article • Annals of the Rheumatic Diseases, September 2018, Elsevier

    Dr Matteo Piga

  134. An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes

    Article • Scientific Reports, July 2018, Springer Science + Business Media

    Professor Rosa Sorrentino, Dr Matteo Piga

  135. Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis

    Article • RMD Open, July 2018, BMJ

    Dr Matteo Piga, Professor Rosa Sorrentino

  136. Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol

    Article • BMJ Open, July 2018, BMJ

    Dr Matteo Piga

  137. Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study

    Article • The Journal of Rheumatology, June 2018, The Journal of Rheumatology

    Dr Matteo Piga

  138. Polymyalgia rheumatica: an autoinflammatory disorder?

    Article • RMD Open, June 2018, BMJ

    Dr Matteo Piga

  139. Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset

    Article • Lupus, May 2018, SAGE Publications

    Dr Matteo Piga, Gian Domenico Sebastiani

  140. Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Dr Matteo Piga, Gian Luca Erre, Barbara Tolusso, Arduino Mangoni

  141. Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Dr Matteo Piga, Gian Luca Erre, Dr Alberto Floris, Arduino Mangoni

  142. Atherosclerosis and Autoimmunity

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Dr Matteo Piga

  143. Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

    Article • Reumatismo, December 2017, PAGEPress Publications

    Dr Matteo Piga

  144. Re: “Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination”

    Article • Ultrasound in Medicine & Biology, December 2017, Elsevier

    Dr Matteo Piga

  145. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus

    Article • November 2017, Springer Science + Business Media

    Dr Matteo Piga

  146. Rituximab is a valid alternative to standard of care in severe inflammatory neuropsychiatric lupus.

    Article • Open Access Rheumatology Research and Reviews, September 2017, Dove Medical Press

    Dr Matteo Piga, Dr Alberto Floris

  147. Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease

    Article • Rheumatology, August 2017, Oxford University Press (OUP)

    Dr Matteo Piga

  148. Telemedicine for patients with rheumatic diseases: Systematic review and proposal for research agenda

    Article • Seminars in Arthritis and Rheumatism, August 2017, Elsevier

    Dr Matteo Piga

  149. Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus

    Article • Lupus, June 2017, SAGE Publications

    Dr Matteo Piga

  150. Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

    Article • Frontiers in Pharmacology, June 2017, Frontiers

    Dr Matteo Piga

  151. Overexpression of the Cytokine BAFF and Autoimmunity Risk

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2017, New England Journal of Medicine (NEJM/MMS)

    Dr Matteo Piga

  152. Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis

    Article • Autoimmunity Reviews, March 2017, Elsevier

    Dr Matteo Piga

  153. Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Gian Luca Erre, Dr Matteo Piga, Arduino Mangoni, Dr Salvatore Sotgia

  154. Pachydermopériostose, un cas d’épanchement articulaire volumineux avec atteinte polyarticulaire imitant l’arthrite juvénile idiopathique

    Article • Revue du Rhumatisme, December 2016, Elsevier

    Dr Matteo Piga

  155. Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography

    Article • October 2016, Springer Science + Business Media

    Dr Matteo Piga, Professor Luca Saba

  156. Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study

    Article • Seminars in Arthritis and Rheumatism, October 2016, Elsevier

    Dr Matteo Piga

  157. Hand tele-rehabilitation system

    Article • Journal of Telemedicine and Telecare, July 2016, SAGE Publications

    Dr Danilo Pani, Dr Matteo Piga, luigi raffo

  158. Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review

    Article • Autoimmunity Reviews, July 2016, Elsevier

    Dr Matteo Piga

  159. Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology

    Article • Rheumatology, June 2016, Oxford University Press (OUP)

    Dr Matteo Piga

  160. Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report

    Article • Joint Bone Spine, January 2016, Elsevier

    Dr Matteo Piga

  161. The Ankylosing Spondylitis-Associated HLA-B*2705 Presents a B*0702-Restricted EBV Epitope and Sustains the Clonal Amplification of Cytotoxic T Cells in Patients

    Article • Extremophiles, January 2016, The Feinstein Institute for Medical Research (North Shore LIJ Research Institute)

    Dr Matteo Piga, Professor Rosa Sorrentino

  162. The Difficult Task of Assessing Psoriatic Arthritis

    Article • The Journal of Rheumatology, December 2015, The Journal of Rheumatology

    Dr Matteo Piga

  163. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol

    Article • Journal of Rheumatology Supplement, November 2015, The Journal of Rheumatology

    Dr Matteo Piga

  164. Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)

    Article • ImmunoTargets and Therapy, October 2015, Dove Medical Press

    Dr Alberto Floris, Dr Matteo Piga

  165. Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012

    Article • Rheumatology International, July 2015, Springer Science + Business Media

    Dr Matteo Piga

  166. Epidemiology of systemic lupus erythematosus in Sardinia.

    Article • Lupus, July 2015, SAGE Publications

    Dr Matteo Piga

  167. Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: Factors associated with accrual of damage and central nervous system involvement

    Article • Autoimmunity Reviews, June 2015, Elsevier

    Dr Matteo Piga

  168. Early Lupus Project – A multicentre Italian study on systemic lupus erythematosus of recent onset

    Article • Lupus, May 2015, SAGE Publications

    Dr Matteo Piga

  169. Killer-Cell Immunoglobulin-Like Receptors (KIR) and HLA-Class I Heavy Chains in Ankylosing Spondylitis

    Article • Drug Development Research, November 2014, Wiley

    Dr Matteo Piga

  170. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus

    Article • Rheumatology, October 2014, Oxford University Press (OUP)

    Dr Matteo Piga

  171. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort

    Article • Autoimmunity Reviews, August 2014, Elsevier

    Dr Matteo Piga

  172. Clinical potential of apremilast in the treatment of psoriatic arthritis

    Article • ImmunoTargets and Therapy, June 2014, Taylor & Francis

    Dr Matteo Piga

  173. Telemedicine Applied to Kinesiotherapy for Hand Dysfunction in Patients with Systemic Sclerosis and Rheumatoid Arthritis: Recovery of Movement and Telemonitoring Technology

    Article • The Journal of Rheumatology, June 2014, The Journal of Rheumatology

    Dr Matteo Piga, luigi raffo

  174. A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients

    Article • IEEE Journal of Translational Engineering in Health and Medicine, January 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Matteo Piga, luigi raffo

  175. Section 2: Spondyloarthritis

    Article • Clinical Drug Investigation, August 2013, Springer Science + Business Media

    Dr Matteo Piga

  176. The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09

    Article • Rheumatology, June 2013, Oxford University Press (OUP)

    Dr Matteo Piga

  177. Rituximab treatment for ‘rhupus syndrome’: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study

    Article • Lupus, April 2013, SAGE Publications

    Dr Matteo Piga

  178. An Integrated Portable Device for the Hand Functional Assessment in the Clinical Practice

    Article • January 2013, Springer Science + Business Media

    Dr Matteo Piga, luigi raffo

  179. Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Dr Matteo Piga

  180. Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients

    Article • Rheumatology, September 2012, Oxford University Press (OUP)

    Dr Matteo Piga

  181. Myocardial Positron Emission Tomography/Computed Tomography Scan Revealing Right Coronary Artery Involvement in Large Vessel Vasculitis

    Article • The Journal of Rheumatology, August 2012, The Journal of Rheumatology

    Dr Matteo Piga

  182. Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time

    Article • Scandinavian Journal of Rheumatology, February 2012, Taylor & Francis

    Dr Matteo Piga, Professor Rosa Sorrentino

  183. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients

    Article • Rheumatology, November 2011, Oxford University Press (OUP)

    Dr Matteo Piga

  184. Managing CNS involvement in systemic lupus erythematosus

    Article • International Journal of Clinical Rheumatology, October 2011, OMICS Publishing Group

    Dr Matteo Piga

  185. Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?

    Article • Lupus, September 2011, SAGE Publications

    Dr Matteo Piga

  186. GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS

    Article • Reumatismo, September 2011, PAGEPress Publications

    Dr Matteo Piga

  187. Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis

    Article • JCR Journal of Clinical Rheumatology, December 2010, Wolters Kluwer Health

    Dr Matteo Piga

  188. Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region

    Article • Rheumatology, November 2010, Oxford University Press (OUP)

    Dr Matteo Piga

  189. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al

    Article • Scandinavian Journal of Rheumatology, November 2010, Taylor & Francis

    Dr Matteo Piga

  190. Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus

    Article • The Journal of Rheumatology, November 2010, The Journal of Rheumatology

    Dr Matteo Piga

  191. Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study

    Article • Lupus, April 2010, SAGE Publications

    Dr Matteo Piga

  192. Familial chilblain and late contractural arachnodactyly: A novel association?

    Article • Joint Bone Spine, March 2009, Elsevier

    Dr Matteo Piga

  193. Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission

    Article • Clinical Rheumatology, September 2008, Springer Science + Business Media

    Dr Matteo Piga